Sun Pharma Announces Top-Line Results from the Phase 2 Clinical Trials Evaluating SCD-044 for Moderate to Severe Psoriasis and Atopic Dermatitis by ananthi | Jun 3, 2025 | Press ReleasesRead More
Press Release Completion of Checkpoint Acquisition by ananthi | May 30, 2025 | Press ReleasesRead More
Sun Pharma reports Q4 and full year results for FY25 by ananthi | May 22, 2025 | Press ReleasesRead More
Recent Comments